Altria Group Announces $2.4 Billion Strategic Investment in Cronos Group
Goodmans LLP acted for Altria Group, Inc. (NYSE:MO) (“Altria”) in connection with its agreement to acquire newly issued shares in Cronos Group Inc. (“Cronos Group”) (TSX: CRON and NASDAQ: CRON), a leading global cannabis company, headquartered in Toronto, Canada.
Pursuant to the transaction, Altria will acquire (i) a 45% equity stake in Cronos Group, at a price of C$16.25 per share, for an aggregate investment by Altria of approximately C$2.4 billion (approximately US$1.8 billion) and (ii) a warrant to acquire an additional 10% equity stake in Cronos Group at a price of C$19.00 per share exercisable over four years from the closing date. If exercised in full, the warrant would increase Altria’s ownership in Cronos Group to approximately 55%. This strategic partnership provides Cronos Group with additional financial resources, product development and commercialization capabilities, and deep regulatory expertise to better position Cronos Group to compete, scale and lead the rapidly growing global cannabis industry. The transaction is expected to close in the first half of 2019, subject to certain customary closing conditions.
Altria Group is the parent company of Philip Morris USA, U.S. Smokeless Tobacco Company, John Middleton, Nat Sherman, Nu Mark, Ste. Michelle Wine Estates and Philip Morris Capital Corporation.
Cronos Group is a globally diversified and vertically integrated cannabis company with a presence across five continents.
Featured Work
-
Mergers and Acquisitions
FINSIGHT Group Inc. announces intent to vote against Q4 Inc’s proposed plan to be acquired by Sumeru Equity Partners
Goodmans is acting for FINSIGHT Group Inc in connection with issuing a letter to the board of directors of Q4 Inc, announcing that it intends to vote AGAINST the Q4 Inc’s proposed plan of arrangement… -
Mergers and Acquisitions
Browning West issues letter to Gildan Activewear’s board of directors outlining steps to restore stakeholder confidence
Goodmans LLP is acting for Browning West, LP in connection with issuing a letter to Gildan Activewear Inc. advocating for the reinstatement of its former CEO, Glenn Chamandy… -
Mergers and Acquisitions
Apotex to acquire Searchlight Pharma
Goodmans LLP is acting for Apotex Inc. in connection with its acquisition of Searchlight Pharma Inc… -
Mergers and Acquisitions
FASHIONPHILE acquires Two Authenticators Business
Goodmans LLP acted for FASHIONPHILE, LLC in connection with its purchase of the assets of Two Authenticators Inc… -
Mergers and Acquisitions
Bazaarvoice Inc. acquires Granify Inc.
Goodmans acted for Bazaarvoice Inc., a leading platform for full-funnel authentic user-generated content and social commerce, in relation with it’s acquisition of Granify Inc., an e-commerce company… -
Mergers and Acquisitions
Majority interest in Kensington Capital Partners Limited acquired by AGF Private Capital Inc.
Goodmans acted for Kensington Capital Partners in connection with AGF Private Capital Inc.'s acquisition of a majority interest in Kensington. Kensington is one of Canada’s leading alternative…